Karen S. Marder, MD, MPH
![Karen S. Marder, MD, MPH Profile Headshot](https://www.columbiapsychiatry.org/sites/default/files/styles/cola_media_200/public/cups-profile/headshot/11ac9bc0-1c20-11ee-bb84-c18a5e62c6ba.jpg?itok=vn8X_sty 200w, https://www.columbiapsychiatry.org/sites/default/files/styles/cola_media_260/public/cups-profile/headshot/11ac9bc0-1c20-11ee-bb84-c18a5e62c6ba.jpg?itok=QRKMPc9l 260w, https://www.columbiapsychiatry.org/sites/default/files/styles/cola_media_320/public/cups-profile/headshot/11ac9bc0-1c20-11ee-bb84-c18a5e62c6ba.jpg?itok=OUPqGdmn 320w, https://www.columbiapsychiatry.org/sites/default/files/styles/cola_media_400/public/cups-profile/headshot/11ac9bc0-1c20-11ee-bb84-c18a5e62c6ba.jpg?itok=wgOgWkQ4 400w, https://www.columbiapsychiatry.org/sites/default/files/styles/cola_media_520/public/cups-profile/headshot/11ac9bc0-1c20-11ee-bb84-c18a5e62c6ba.jpg?itok=f4VwmHMq 520w, https://www.columbiapsychiatry.org/sites/default/files/styles/cola_media_640/public/cups-profile/headshot/11ac9bc0-1c20-11ee-bb84-c18a5e62c6ba.jpg?itok=HPeCcwVz 640w, https://www.columbiapsychiatry.org/sites/default/files/styles/cola_media_800/public/cups-profile/headshot/11ac9bc0-1c20-11ee-bb84-c18a5e62c6ba.jpg?itok=8H9uJ8nx 800w)
Overview
Karen Marder, MD, MPH is the Sally Kerlin Professor of Neurology at Columbia University Irving Medical Center. She has served as the Chief of the Division of Aging and Dementia since 2001 and has directed the United Council for Neurologic Subspecialties (UCNS) fellowship in Behavioral Neurology and Neuropsychiatry since its inception.
In both research and patient care, Dr. Marder is focused on the epidemiology and treatment of cognitive, behavioral, and motor impairments in a range of neurodegenerative diseases, including Parkinson’s disease (PD), Huntington’s Disease (HD), HIV dementia, Dementia with Lewy bodies (DLB) and related disorders.
Her research has focused on characterizing the earliest motor and non-motor signs associated with genetic forms of PD. She served as co-chair and chair of the Executive Committee of the Parkinson Study Group (2006-2012), a consortium of North American investigators participating in collaborative PD research at 120 sites. She is the founding (1991) and current director of the multidisciplinary Huntington's Disease Society of America Center of Excellence at Columbia which serves over 250 families receiving clinical care and participating in clinical trials and observational studies. She serves as associate director of the Irving Institute for Clinical and Translational Research (CTSA). In addition, Dr. Marder is a principal investigator of the Columbia University–Weill Cornell NIH-funded NeuroNEXT site, a clinical trial network whose goal is to conduct Phase II biomarker informed neurological clinical trials.
Areas of Expertise / Conditions Treated
- Alzheimer's Disease
- Frontotemporal Dementia
- Huntington's Disease (HD)
- Lewy Body Disease
- Memory Loss
Academic Appointments
- Sally Kerlin Professor of Neurology (in the Gertrude H. Sergievsky Center, in the Taub Institute on Alzheimer's Disease and the Aging Brain, and in Psychiatry) at CUMC
Administrative Titles
- Chief, Division of Aging and Dementia
- Associate Director, Irving Institute for Clinical and Translational Research
- Director, Clinical Research Resource, Irving Institute
- Director, Huntington's Disease Center
Hospital Affiliations
- NewYork-Presbyterian / Columbia University Irving Medical Center
Gender
- Female
Schedule an Appointment
Virtual Visits/Telehealth
Virtual Visits allow you to connect with your provider from the comfort, convenience, and safety of your own home.
Phone Appointments
Connect Patient Portal
For existing patients, login to make an appointment, view documentation or contact your care provider.
Location(s)
Insurance Accepted
Aetna
- Aetna Signature Administrators
- EPO
- HMO
- Medicare Managed Care
- NYP Employee Plan
- NY Signature
- POS
- PPO
- Student Health
Affinity Health Plan
- Essential Plan
- Medicaid Managed Care
AgeWell
- Medicare Managed Care
- Special Needs
Amida Care
- Special Needs
Cigna
- EPO
- Great West (National)
- HMO
- Medicare Managed Care
- POS
- PPO
Emblem/GHI
- Medicare Managed Care
- PPO
Emblem/HIP
- ConnectiCare
- EPO
- Essential Plan
- HMO
- Medicaid Managed Care
- Medicare Managed Care
- POS
- PPO
- Select Care (Exchange)
- Vytra
Empire Blue Cross/Blue Shield
- EPO
- HMO
- Medicare Managed Care
- PPO
Empire Blue Cross Blue Shield HealthPlus
- Child/Family Health Plus
- Essential Plan
- Medicaid Managed Care
Fidelis Care
- Child/Family Health Plus
- Essential Plan
- Medicaid Managed Care
- Medicare Managed Care
Healthfirst
- Child/Family Health Plus
- Leaf (Exchange)
- Medicaid Managed Care
- Medicare Managed Care
Local 1199
- Local 1199
MagnaCare (National)
- MagnaCare
Medicare
- Railroad
- Traditional Medicare
Multiplan
- Multiplan
MVP Health Care
- Child/Family Health Plus
- Essential Plan
- HMO
- Medicaid Managed Care
Quality Health Management
- Quality Health Management
RiverSpring
- Special Needs
UnitedHealthcare
- Compass (Exchange)
- Empire Plan
- HMO
- Medicaid (Community Plan)
- Medicare Managed Care
- Oxford Freedom
- Oxford HMO
- Oxford Liberty
- POS
- PPO
VNSNY CHOICE
- Medicare Managed Care
- SelectHealth
- Special Needs
WellCare
- Medicaid Managed Care
- Medicare Managed Care
World Trade Center Health Plan
- World Trade Center Health Plan
Credentials & Experience
Education & Training
- Cornell University Medical College, NY
- Internship: St. Luke's-Roosevelt Hospital Center
- Residency: Columbia University Medical Center
- Fellowship: Columbia University Medical Center
Board Certifications
- Neurology
Research
Dr. Marder's research has focused on the epidemiology and treatment of cognitive, behavioral, and motor impairments in a range of neurodegenerative diseases, including Parkinson’s disease (PD), Huntington’s Disease (HD), HIV dementia, and Alzheimer’s disease (AD) and related disorders. Most recently, my focus has been on characterizing the earliest signs associated with genetic forms of PD including Parkin, LRRK2, and GBA mutations, especially in individuals with early-onset PD.
In May 2006, I was elected to a 6-year term as co-chair of the Executive Committee of the Parkinson Study Group, a consortium of North American investigators participating in collaborative PD research at 120 sites.
I established the Huntington's Disease Society of America Center of Excellence at Columbia University in 1991, which I continue to lead today. We conduct a wide range of observational research and clinical trials for people with HD and those at risk.
I am particularly interested in the knowledge and attitudes of people at risk for genetic disorders. At Columbia, I also serve as associate director of the Irving Institute for Clinical and Translational Research (CTSA) where I direct the Clinical Research Resource for adult and pediatric inpatient and outpatient research. I am also the co-Principal Investigator for the Columbia/Weill-Cornell site of the NINDS-funded NeuroNEXT clinical trial network, whose mission is to conduct Phase 2 biomarker informed studies of neurological diseases.
Research Interests
- Neuropsychiatry/Cognitive Disorders
For a complete list of publications, please visit PubMed.gov